IL2 and cancer: The identified pathways are shown in Figure 5A. Several signaling pathways well-known in cancer were identified such as KRAS signaling UP, IL-6/JAK/STAT3 signaling, IL-2/STAT5 signaling, TNF-alpha signaling via NF-kB as well as epithelial–mesenchymal transition and apoptosis.